Priority Date: 21.02.12 (US 201261601326P)

PHARMACEUTICAL COMPOSITION COMPRISING CD34+ CELLS

  • Application ID: EP13710647
  • Status: █ APPLICATION DEEMED TO BE WITHDRAWN

Applicants

Technology company logo small
Baxter Healthcare SA
Technology Company
Technology company logo small
Baxter International Inc
Technology Company

Attorney

Employment test 51 - 200 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna potter clarkson llp
operating since 1889
1071.86
Potter Clarkson LLP
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Potter Clarkson LLP is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 170 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 21.02.2012 - Priority Date (US 201261601326P)
  • 29.08.2013 - Publication A2 (WO2013126590)
  • 31.12.2014 - Publication A2 (EP2817014)